vs
Side-by-side financial comparison of Expensify, Inc. (EXFY) and Inogen Inc (INGN). Click either name above to swap in a different company.
Inogen Inc is the larger business by last-quarter revenue ($68.6M vs $35.2M, roughly 1.9× Expensify, Inc.). On growth, Inogen Inc posted the faster year-over-year revenue change (3.4% vs -4.9%). Over the past eight quarters, Inogen Inc's revenue compounded faster (4.2% CAGR vs 2.4%).
Expensify, Inc. is a software company that develops an expense management system for personal and business use. Expensify also offers a business credit card called the Expensify Card.
Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.
EXFY vs INGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $35.2M | $68.6M |
| Net Profit | — | — |
| Gross Margin | 49.2% | 51.4% |
| Operating Margin | -11.2% | -13.6% |
| Net Margin | — | — |
| Revenue YoY | -4.9% | 3.4% |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.07 | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.2M | $68.6M | ||
| Q3 25 | $35.1M | $79.1M | ||
| Q2 25 | $35.8M | $79.2M | ||
| Q1 25 | $36.1M | $68.5M | ||
| Q4 24 | $37.0M | $66.3M | ||
| Q3 24 | $35.4M | $74.9M | ||
| Q2 24 | $33.3M | $74.4M | ||
| Q1 24 | $33.5M | $63.1M |
| Q4 25 | — | — | ||
| Q3 25 | $-2.3M | $-5.3M | ||
| Q2 25 | $-8.8M | $-4.2M | ||
| Q1 25 | $-3.2M | $-6.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.2M | $-6.0M | ||
| Q2 24 | $-2.8M | $-5.6M | ||
| Q1 24 | $-3.8M | $-14.6M |
| Q4 25 | 49.2% | 51.4% | ||
| Q3 25 | 49.6% | 52.2% | ||
| Q2 25 | 51.9% | 52.2% | ||
| Q1 25 | 50.6% | 53.1% | ||
| Q4 24 | 51.0% | 54.7% | ||
| Q3 24 | 51.6% | 55.2% | ||
| Q2 24 | 56.9% | 57.4% | ||
| Q1 24 | 56.5% | 54.5% |
| Q4 25 | -11.2% | -13.6% | ||
| Q3 25 | -6.4% | -9.0% | ||
| Q2 25 | -28.9% | -7.7% | ||
| Q1 25 | -4.1% | -11.2% | ||
| Q4 24 | 1.3% | -17.2% | ||
| Q3 24 | 0.8% | -10.4% | ||
| Q2 24 | 0.7% | -9.5% | ||
| Q1 24 | -5.3% | -25.8% |
| Q4 25 | — | — | ||
| Q3 25 | -6.6% | -6.7% | ||
| Q2 25 | -24.6% | -5.2% | ||
| Q1 25 | -8.8% | -9.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | -6.2% | -8.0% | ||
| Q2 24 | -8.3% | -7.5% | ||
| Q1 24 | -11.3% | -23.1% |
| Q4 25 | $-0.07 | $-0.26 | ||
| Q3 25 | $-0.03 | $-0.20 | ||
| Q2 25 | $-0.10 | $-0.15 | ||
| Q1 25 | $-0.03 | $-0.25 | ||
| Q4 24 | $-0.03 | $-0.41 | ||
| Q3 24 | $-0.02 | $-0.25 | ||
| Q2 24 | $-0.03 | $-0.24 | ||
| Q1 24 | $-0.04 | $-0.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.1M | $103.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $132.7M | $192.2M |
| Total Assets | $186.0M | $298.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.1M | $103.7M | ||
| Q3 25 | $61.5M | $106.5M | ||
| Q2 25 | $60.5M | $103.7M | ||
| Q1 25 | $59.6M | $118.9M | ||
| Q4 24 | $48.8M | $113.8M | ||
| Q3 24 | $39.2M | $105.7M | ||
| Q2 24 | $53.2M | $97.9M | ||
| Q1 24 | $49.3M | $107.4M |
| Q4 25 | $132.7M | $192.2M | ||
| Q3 25 | $135.7M | $197.2M | ||
| Q2 25 | $131.8M | $199.5M | ||
| Q1 25 | $134.7M | $198.0M | ||
| Q4 24 | $128.2M | $173.9M | ||
| Q3 24 | $119.9M | $185.4M | ||
| Q2 24 | $114.0M | $187.6M | ||
| Q1 24 | $106.5M | $191.9M |
| Q4 25 | $186.0M | $298.6M | ||
| Q3 25 | $186.8M | $307.0M | ||
| Q2 25 | $187.1M | $312.0M | ||
| Q1 25 | $189.2M | $308.4M | ||
| Q4 24 | $173.7M | $296.2M | ||
| Q3 24 | $176.2M | $306.2M | ||
| Q2 24 | $192.9M | $308.9M | ||
| Q1 24 | $184.8M | $315.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.2M | $-943.0K |
| Free Cash FlowOCF − Capex | — | $-1.9M |
| FCF MarginFCF / Revenue | — | -2.8% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.2M | $-943.0K | ||
| Q3 25 | $4.2M | $2.2M | ||
| Q2 25 | $8.9M | $4.3M | ||
| Q1 25 | $4.8M | $-16.8M | ||
| Q4 24 | $7.4M | $-3.0M | ||
| Q3 24 | $3.7M | $7.0M | ||
| Q2 24 | $9.3M | $6.7M | ||
| Q1 24 | $3.5M | $-4.7M |
| Q4 25 | — | $-1.9M | ||
| Q3 25 | — | $1.6M | ||
| Q2 25 | — | $3.7M | ||
| Q1 25 | — | $-17.1M | ||
| Q4 24 | — | $-3.3M | ||
| Q3 24 | — | $5.3M | ||
| Q2 24 | — | $6.6M | ||
| Q1 24 | — | $-6.1M |
| Q4 25 | — | -2.8% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | -24.9% | ||
| Q4 24 | — | -5.0% | ||
| Q3 24 | — | 7.1% | ||
| Q2 24 | — | 8.9% | ||
| Q1 24 | — | -9.6% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | 0.0% | 0.5% | ||
| Q3 24 | 0.0% | 2.2% | ||
| Q2 24 | 0.0% | 0.1% | ||
| Q1 24 | 0.0% | 2.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EXFY
Segment breakdown not available.
INGN
| Other | $36.1M | 53% |
| Non Us | $32.5M | 47% |
